Impaired global myocardial flow dynamics despite normal left ventricular function and regional perfusion in chronic

Kenji Fukushima1, Mehrbod S Javadi, Takahiro Higuchi

  • 1Division of Nuclear Medicine, Russell H. Morgan Department of Radiology, Johns Hopkins University, Baltimore, Maryland, USA.

Insights

Chronic kidney disease (CKD) impairs myocardial flow reserve (MFR) primarily due to increased resting blood flow, not reduced stress flow. This microvascular dysfunction is linked to reduced kidney function.

Area of Science:

  • Cardiology
  • Nephrology
  • Nuclear Medicine

Background:

  • Impaired myocardial flow reserve (MFR) is linked to cardiac events and coronary artery disease (CAD).
  • Chronic kidney disease (CKD) is an independent risk factor for cardiovascular disease.
  • The impact of CKD on myocardial microcirculation in patients without obstructive CAD is not well understood.

Purpose of the Study:

  • To investigate the effect of CKD on myocardial microcirculation.
  • To assess myocardial blood flow (MBF) and MFR in CKD patients with normal left ventricular (LV) function and no flow-limiting CAD.

Main Methods:

  • Utilized Rubidium-82 (82Rb) PET/CT in 40 CKD patients and 42 matched controls.
  • Quantified MBF and MFR using a validated retention model.
  • Excluded patients with hemodialysis, renal transplant, abnormal perfusion, or reduced LV function.

Main Results:

  • CKD patients had significantly reduced MFR (2.2 ± 1.0 vs. 3.0 ± 1.2, P = 0.027).
  • Elevated resting MBF (1.1 ± 0.4 vs. 0.8 ± 0.2 mL/min/g, P = 0.007) was the primary driver of reduced MFR in CKD.
  • MFR significantly correlated with estimated glomerular filtration rate (eGFR) (r = 0.41; P = 0.0005).

Conclusions:

  • MFR is impaired in CKD patients with preserved LV function and normal regional perfusion.
  • Elevated resting MBF, not reduced stress MBF, underlies MFR impairment in CKD.
  • Absolute MBF quantification may identify microvascular dysfunction as a precursor to CAD in CKD patients.
Abstract